In order to create sustainable value to patients, shareholders and to the community Sobi supports different transparency initiatives, including transparency interactions with healthcare and regarding clinical trials.
Payments to Healthcare
Collaboration between physicians and the healthcare industry has for long been a positive driver for advancements in patient care and progression of innovative medicine. In order to secure future collaboration and to increase public awareness we support transparency initiatives, including the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code in Europe and the Physician Payments Sunshine Act in the United States.
Use company name “Sobi” for US payments and “Swedish Orphan Biovitrum” for non-US payments